Lashch N Yu, Pavlikov A E, Boyko A N
Pirogov Russian National Research Medical University, Moscow, Russia.
²Federal Center for Brain and Neurotechnologies, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(9):21-25. doi: 10.17116/jnevro202312309121.
Multiple sclerosis (MS) is a common neurological disease among young people of working age, which tends to increase the number of cases registered in the world and in the Russian Federation. However, with improved diagnostics and the emergence of new drugs that change the course of MS (disease-modifying therapy), people's life expectancy increases and the percentage of patients in the older age group increases as well. In this article, we consider the possibility of developing MS among people over 50 years of age, features of the course, diagnosis and treatment.
